Politics
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value
Key Points
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. The round could value Isomorphic as highly as $50 billion, one of the people said. The financing hasn’t closed and details could change, the people said.
Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.
The round could value Isomorphic as highly as $50 billion, one of the people said. The financing hasn’t closed and details could change, the people said. Isomorphic did not respond to a request for comment.